Zions Bancorporation’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $10.7M | Buy |
188,331
+20,480
| +12% | +$1.14M | 0.67% | 19 |
|
|
2024
Q3 | $8.68M | Buy |
167,851
+23,001
| +16% | +$1.08M | 0.63% | 20 |
|
|
2024
Q2 | $6.02M | Buy |
144,850
+52,587
| +57% | +$2.35M | 0.48% | 34 |
|
|
2024
Q1 | $5M | Buy |
92,263
+88,126
| +2,130% | +$4.49M | 0.37% | 50 |
|
|
2023
Q4 | $212K | Sell |
4,137
-29
| -0.7% | -$1.52K | 0.01% | 313 |
|
|
2023
Q3 | $242K | Sell |
4,166
-131
| -3% | -$8.03K | 0.02% | 293 |
|
|
2023
Q2 | $275K | Sell |
4,297
-162
| -4% | -$10.9K | 0.02% | 286 |
|
|
2023
Q1 | $309K | Buy |
4,459
+12
| +0.3% | +$846 | 0.03% | 277 |
|
|
2022
Q4 | $320K | Sell |
4,447
-23,487
| -84% | -$1.77M | 0.03% | 278 |
|
|
2022
Q3 | $1.99M | Sell |
27,934
-22,521
| -45% | -$1.63M | 0.21% | 79 |
|
|
2022
Q2 | $3.88M | Sell |
50,455
-12,634
| -20% | -$962K | 0.39% | 44 |
|
|
2022
Q1 | $4.61M | Buy |
63,089
+37,473
| +146% | +$2.52M | 0.41% | 32 |
|
|
2021
Q4 | $1.6M | Buy |
25,616
+23,722
| +1,252% | +$1.39M | 0.14% | 89 |
|
|
2021
Q3 | $112K | Sell |
1,894
-64
| -3% | -$4.21K | 0.01% | 354 |
|
|
2021
Q2 | $131K | Sell |
1,958
-504
| -20% | -$32.9K | 0.01% | 325 |
|
|
2021
Q1 | $155K | Sell |
2,462
-14,704
| -86% | -$915K | 0.02% | 303 |
|
|
2020
Q4 | $1.06M | Sell |
17,166
-741
| -4% | -$45.6K | 0.13% | 77 |
|
|
2020
Q3 | $1.08M | Buy |
17,907
+4,647
| +35% | +$280K | 0.15% | 67 |
|
|
2020
Q2 | $780K | Buy |
13,260
+10,733
| +425% | +$642K | 0.11% | 79 |
|
|
2020
Q1 | $141K | Sell |
2,527
-1,669
| -40% | -$102K | 0.02% | 220 |
|
|
2019
Q4 | $269K | Buy |
4,196
+518
| +14% | +$29.7K | 0.04% | 160 |
|
|
2019
Q3 | $186K | Sell |
3,678
-1,113
| -23% | -$52.3K | 0.03% | 258 |
|
|
2019
Q2 | $218K | Buy |
4,791
+146
| +3% | +$6.8K | 0.03% | 210 |
|
|
2019
Q1 | $222K | Buy |
+4,645
| New | +$231K | 0.04% | 198 |
|
|
2018
Q2 | – | Sell |
-9,133
| Closed | -$577K | – | 469 |
|
|
2018
Q1 | $577K | Buy |
9,133
+5
| +0.1% | +$322 | 0.13% | 64 |
|
|
2017
Q4 | $559K | Sell |
9,128
-604
| -6% | -$37.8K | 0.1% | 85 |
|
|
2017
Q3 | $620K | Buy |
9,732
+3,771
| +63% | +$220K | 0.09% | 129 |
|
|
2017
Q2 | $332K | Sell |
5,961
-91
| -2% | -$4.95K | 0.06% | 126 |
|
|
2017
Q1 | $328K | Sell |
6,052
-607
| -9% | -$33.3K | 0.06% | 97 |
|
|
2016
Q4 | $389K | Sell |
6,659
-30
| -0.4% | -$1.64K | 0.07% | 91 |
|
|
2016
Q3 | $347K | Sell |
6,689
-307
| -4% | -$19.7K | 0.07% | 91 |
|
|
2016
Q2 | $522K | Buy |
6,996
+187
| +3% | +$13.2K | 0.09% | 87 |
|
|
2016
Q1 | $466K | Buy |
6,809
+1,278
| +23% | +$80.6K | 0.08% | 89 |
|
|
2015
Q4 | $343K | Buy |
5,531
+434
| +9% | +$28.7K | 0.06% | 97 |
|
|
2015
Q3 | $325K | Sell |
5,097
-3,464
| -40% | -$220K | 0.06% | 92 |
|
|
2015
Q2 | $570K | Buy |
8,561
+3,140
| +58% | +$207K | 0.09% | 95 |
|
|
2015
Q1 | $350K | Buy |
+5,421
| New | +$339K | 0.06% | 106 |
|
Other funds holding BMY
Zions Bancorporation's BMY Position: Q4 2024 in Review
Zions Bancorporation increased its Bristol-Myers Squibb (BMY) stake by 12% in Q4 2024, buying an estimated $1.14M and bringing the position to 188,331 shares worth $10.7M. The position accounts for 0.67% of the portfolio, ranked #19.
Zions Bancorporation first reported a position in BMY in Q1 2015 and has held it in 37 quarters since. 2,487 funds tracked by Wall St. Rank hold BMY as of Q4 2024.
- Zions Bancorporation held 188,331 shares of Bristol-Myers Squibb worth $10.7M as of Q4 2024.
- Zions Bancorporation bought 20,480 Bristol-Myers Squibb shares in Q4 2024, an estimated $1.14M.
- Bristol-Myers Squibb made up 0.67% of Zions Bancorporation's portfolio in Q4 2024, its #19 holding.
- Zions Bancorporation first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 37 quarters since.
- 2,487 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.